{"name":"Zhittya Genesis Medicine, Inc.","slug":"zhittya-genesis-medicine-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2AJBVV95cUxORUF3eHlvT3V1MHM2VkpVRk1WRk1yY1oxYTB5MHpqd0hiUl9KZWh4NmQ5Ul9NOFZjNC1NeS1TTzRvRE9mUE80UmNYMWJTUmF0X19JRC1zdklVU09wYWN3Q3pzS180Smh2cnlRSmRnSm9nZjF4RzFIMkZPZzhYM1RoVHdESUpnNzFzVlpDM1cxNDVlbndYRjlILUx6U2NHVHVLMnNNNktON05HQ3JHcTNzSzRoMlJOaWlpdzlCQXQwMWNpMnNrbHRUakdaRTJ0d0RPZjBudWVrWFB2T2RFcW11cTRkLVloTnJWS21HYUV6eFlpQ3hmbGNoRmh6a25XY1RqT0l5MnVHZmtVVEh0RV9uRmhqV0daa1k2a0xRN00xRXI0WTNLRmRZZm9zSWFsRXQ5eG9wTkpGNzRHckZvelZIY3o1djJoNHhzY1FCbG9ySTZlYlJKbmhQTw?oc=5","date":"2025-02-27","type":"trial","source":"GlobeNewswire","summary":"Zhittya Genesis Medicine Announces: Landmark fMRI Study - GlobeNewswire","headline":"Zhittya Genesis Medicine Announces: Landmark fMRI Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxQdkJ0b2h2Q3o4enFWZ2pIaGd4cG1aSUtKaTF5SXZqMnViOTM5QkJKZXNabTdmUW91M0hoWGhaOTdSeHN2eXVxZ0NoS0pTNjYyd1V2aW5Ob2VvZWE2RHlXZU43STNqSEpnQ2p2VXRKNGxYRHhzdi1ySkVXNEhIRlRyNlg3TUY4eUlhTXBvUlA1ek15OWdiQjBVaHB6elhTSm53d29wRjJ4R3ozZXgtdENxRW5qVDF6R3N3a2t2bGJHeWVQaEhOQmFUczJiald5ZHYzUEVwWG1tRXRUeXdoZTI0YmhlT0M?oc=5","date":"2024-11-02","type":"pipeline","source":"PNI Atlantic News","summary":"'I want to live': P.E.I. man with Parkinson's hopes U.S.-based experimental treatment could restore mobility - PNI Atlantic News","headline":"'I want to live': P.E.I. man with Parkinson's hopes U.S.-based experimental treatment could restore mobility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPYzM4VXczVndhUkx0Sk51WGJZempxYXZaVmNiOHF4elZGaE5aWmJBbnJYRVE3UmtBdkV4bjlzX25va05EZGRhUXhZNzkxSTRXanlUTVp6VDFkbmZ5UW9ILTlSU3A4M2k1UVdqQ2h3ZF93clNGNTZvd25nTGlEZ3FJaUh3QjZDYVFTWUplWXJkZThranhMMVI2a2N0OS0xanRRWWkzZUpXdEdyM3NSMkcyd2FBLVdKWHhDM2xyOVBR?oc=5","date":"2023-05-02","type":"pipeline","source":"Contract Pharma","summary":"3P Bio, Zhittya Complete Process Transfer and GMP Supply for FGF-1 Candidate - Contract Pharma","headline":"3P Bio, Zhittya Complete Process Transfer and GMP Supply for FGF-1 Candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOWEIwWXZNYkhYMzJ5RWIwWUZiWXdzNmFGWUFiNW1kWWZtUG9TdHlqRkVQd2ZrQXNrV1h6RmFwTEZBTUhnbkc4U0piYXd5bm5lY0xUbTg5U3Q3YUpCZEh5YjRmb1pxNkxGOGpST2F1TktObzRfZnZXdmI5eVRwaHRjbEo5emdIU05ScFNYYTZVLWdIV00?oc=5","date":"2022-02-28","type":"pipeline","source":"NeurologyLive","summary":"Rare Disease Day: Updates on Rare Neurological Diseases - NeurologyLive","headline":"Rare Disease Day: Updates on Rare Neurological Diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxORDI2RXdGZ1prbC1VLTVUMGtDeHM1eWpESy1jSjYyUm5YRDNMUUZBaVBWampBbnVOTHZWMDR6TWlwNXlMYnlZaXk5V3NGRmdEd21EQW9jV0dTTjJGVkg1aVZXTS1aZWszWFdVWDJlVGVOeG5jTGtaMGs0aGV4OEdCbGd4aHgyNk9QRFg2dWd2cDZoeVFudi1sS3hROGxJZENxclA4R014SFltdENRaEJOQmQyVQ?oc=5","date":"2022-01-19","type":"trial","source":"NeurologyLive","summary":"Compassionate Use Clinical Trial of FGF-1 Initiated for Amyotrophic Lateral Sclerosis - NeurologyLive","headline":"Compassionate Use Clinical Trial of FGF-1 Initiated for Amyotrophic Lateral Sclerosis","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}